Skip to main content
Operant Scientific
Global presence

22 markets.
One regulatory
backbone.

From ANVISA in Brazil to the HSA in Singapore, we prepare market-specific dossiers and stand behind our chemistry at every inspection. Explore where we ship and who we've registered with.

0+
Markets served
0
Regions covered
0+
Approved products
0 yrs
Regulatory record
Interactive map

Click a marker.

Each dot is a market where we hold a live commercial registration. Click one to see the regulatory authority, dossier format, and typical registration timeline for that market.

22 markets · click to explore
Regional breakdown

Six regions, six regulatory rhythms.

Each region has its own dossier format, inspection culture, and local partnership model. Our RA team maintains an in-house lead for every one.

Asia-Pacific

Seven countries under CTD / ACTD frameworks

7 markets

Our largest regulatory footprint. India (CDSCO), Singapore (HSA), and Australia (TGA) act as reference markets for smaller APAC dossier submissions.

Dossier framework

CTD · ACTD · eCTD

IndiaSingaporeMalaysiaThailandPhilippinesVietnamAustralia

LATAM

Five countries with harmonised CTD submissions

5 markets

ANVISA in Brazil sets the tone for the region; COFEPRIS, INVIMA, DIGEMID, and ISP follow with market-specific local requirements.

Dossier framework

CTD (Spanish/Portuguese)

BrazilMexicoColombiaPeruChile

Middle East

GCC harmonisation with per-market layers

3 markets

UAE, Saudi Arabia, and Egypt anchor the region. Increasing GCC harmonisation is easing multi-country submissions, but Egypt still requires distinct EDA filings.

Dossier framework

GCC CTD · EDA CTD

UAESaudi ArabiaEgypt

Africa

Three anchor markets, more in preparation

3 markets

South Africa (SAHPRA), Nigeria (NAFDAC), and Kenya (PPB) are our current active markets. AMA (African Medicines Agency) harmonisation is expected to reduce per-country burden over the next five years.

Dossier framework

CTD (English)

South AfricaNigeriaKenya

CIS

Russia and Central Asian republics

3 markets

Russia and the Central Asian republics operate on a CTD framework with market-specific translation and local-representative requirements.

Dossier framework

CTD (Russian)

RussiaKazakhstanUzbekistan

Europe

MHRA-aligned regulatory posture

1 market

The UK is our current European regulatory anchor. EU expansion through European partners is on the roadmap, backed by our MHRA-aligned quality system.

Dossier framework

eCTD

United Kingdom
WHO-GMPMHRA alignedcGMPISO 9001ISO 14001ICH Q7ICH Q9ICH Q10ICH Q1B stabilityUSPEPJPWHO-GMPMHRA alignedcGMPISO 9001ISO 14001ICH Q7ICH Q9ICH Q10ICH Q1B stabilityUSPEPJP
Local partnership model

Local distributors,
central QA.

Every market has a named local partner — a distributor, an in-country representative, or a co-marketing arrangement. Regulatory affairs is always run from India so the QA framework stays unified across markets.

Discuss market entry

Named local partner in every market

In-house RA lead per region

Market-specific dossier prep in-house

20+ live commercial registrations

New markets welcome

Entering a market we don't yet serve?

We add new regulatory dossiers every quarter. If your programme requires registration in a market not on our current map, our RA team scopes the effort as part of the initial engagement.

Chat with us